← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.

Mazyar Shadman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39647999